I'm excited to announce the launch of our new website that highlights two very important Eli Lilly global health programs, which we have spotlighted on our blog previously: the Lilly MDR-TB Partnership and the Lilly NCD Partnership. This new website will serve as a place to learn about the enormous impact of multidrug-resistant tuberculosis (MDR-TB) and non-communicable diseases (NCDs) worldwide, as well as to view our progress with our partners as we work to find solutions to these urgent global health challenges.
Please visit www.lillyglobalhealth.com
Rob Oliphant, President and CEO of the Asthma Society of Canada tackles the Canada-EU Comprehensive Economic and Trade Agreement (CETA) in his piece in Huffington Post Canada. Mr. Oliphant stresses the importance of stronger patent protections to patients living with chronic conditions, writing:
"Strengthening Canada's IP standards is not only a key pillar of a trade agreement that will bring greater prosperity to Canada; it will also create an environment that encourages medical innovation and creates new opportunities for patients seeking a cure or relief from pain."
Read the full article: Taking Prescription Medication? You Could Benefit from CETA
Canada is lagging in health technology adoption. Russell Williams, President of Rx&D, Canada's Research Based Pharmaceutical Companies, looked into this issue, why we should be concerned and what is being done about it:
"Early adoption of technologies is a key element to improving our productivity, transforming our economies, sustaining our health care systems and sending a signal that we want to compete and run with the best.
Check out the full piece over at HuffPost Canada: http://www.huffingtonpost.ca/russell-williams/technology-and-healthcare-canada_b_4227253.html
Finally, this week the federal government announced funding for new research projects aimed at preventing, diagnosing and treating concussions. Six research projects in Ontario received total funding of $2.7M from the Canadian Institutes of Health Research (CIHR), Defence Research and Development Canada, Ontario Neurotrauma Foundation and Ontario Brain Institute.
Read more about the projects selected: CIHR Mild Traumatic Brain Injury Research Funding